Vanguard Discloses 9.42M Shares of Acadia Healthcare (10.19%)
Rhea-AI Filing Summary
The Vanguard Group reported owning 9,417,045 shares of Acadia Healthcare Company, Inc., representing 10.19% of the outstanding common stock as of 09/30/2025. Vanguard reports 0 shares of sole voting power, 598,737 shares of shared voting power, 8,718,595 shares of sole dispositive power, and 698,450 shares of shared dispositive power. The filing states these shares are held in the ordinary course of business and not for the purpose of changing or influencing control. The reporting address is 100 Vanguard Blvd., Malvern, PA, and the filing is signed by Ashley Grim, Head of Global Fund Administration, on 10/06/2025.
Positive
- Material passive stake: Vanguard holds 9,417,045 shares, equal to 10.19% of the class
- Clear non‑control intent: Filed on Schedule 13G indicating holdings are ordinary course of business and not to influence control
Negative
- None.
Insights
Vanguard holds a material passive stake of just over 10% in Acadia Healthcare.
Holding 9.42M shares and 10.19% of the class places Vanguard among significant institutional holders; the position is reported under Schedule 13G, which signals a passive, non-control intent.
Key dependencies include whether other large holders file active disclosures; monitor any future amendments or Schedule 13D filings for changes in intent within the next 30–90 days.
The voting profile shows limited sole voting power and meaningful dispositive authority.
Vanguard reports 0 sole voting power but 598,737 shared voting votes and substantial sole dispositive power, indicating control over trades but limited unilateral voting control. This split is common for asset managers holding client-directed accounts.
Watch for proxy-season activity or coordination with other large holders ahead of any significant governance votes in the coming year.
AI-generated analysis. How Rhea-AI works. Not financial advice.